6,500 Shares in Nutex Health Inc. (NASDAQ:NUTX) Acquired by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,500 shares of the company’s stock, valued at approximately $206,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Essex Investment Management Co. LLC acquired a new stake in shares of Nutex Health during the third quarter worth $1,579,000. International Assets Investment Management LLC purchased a new position in Nutex Health in the 3rd quarter worth about $188,000. Thompson Davis & CO. Inc. acquired a new stake in Nutex Health during the 3rd quarter worth about $494,000. State Street Corp acquired a new position in shares of Nutex Health in the third quarter worth about $225,000. Finally, Beaird Harris Wealth Management LLC purchased a new position in shares of Nutex Health in the third quarter worth approximately $69,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Price Performance

NASDAQ NUTX opened at $47.63 on Friday. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The firm has a market capitalization of $258.96 million, a price-to-earnings ratio of -5.07 and a beta of 0.18. The company has a 50 day simple moving average of $35.56 and a 200-day simple moving average of $25.28. Nutex Health Inc. has a 52-week low of $4.16 and a 52-week high of $49.06.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Thursday, November 7th. The company reported ($1.72) earnings per share (EPS) for the quarter. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $78.79 million for the quarter.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on NUTX shares. Benchmark upped their price target on shares of Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a research report on Tuesday, November 12th. Maxim Group raised their target price on Nutex Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, November 12th.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.